Celularity Inc.
CELU
$0.69
-$0.12-15.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -22.33% | -7.88% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -22.33% | -7.88% | |||
| Cost of Revenue | 88.88% | -25.52% | |||
| Gross Profit | -336.96% | 179.35% | |||
| SG&A Expenses | 61.87% | -26.34% | |||
| Depreciation & Amortization | -556.31% | -12.63% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 34.02% | -16.05% | |||
| Operating Income | -57.20% | 19.01% | |||
| Income Before Tax | -5.56% | 5.90% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.57% | 5.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.57% | 5.90% | |||
| EBIT | -57.20% | 19.01% | |||
| EBITDA | -70.21% | 21.05% | |||
| EPS Basic | 1.91% | 14.22% | |||
| Normalized Basic EPS | 21.26% | 12.05% | |||
| EPS Diluted | 1.91% | 14.22% | |||
| Normalized Diluted EPS | 21.26% | 12.05% | |||
| Average Basic Shares Outstanding | 8.00% | 9.69% | |||
| Average Diluted Shares Outstanding | 8.00% | 9.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||